Abstract
Treatment of exocrine pancreatic insufficiency is based on oral administration of pancreatic enzyme-containing preparations. The aim is to prevent or correct malnutrition secondary to exocrine pancreatic insufficiency through a clinically relevant reduction or normalization of faecal fat and nitrogen losses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1979) Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854– 858
Caliari S, Benini L, Bonfante F, Brentegani MT, Fioretta A, Vantini I (1993) Pancreatic extracts are necessary for the absorption of elemental and polymeric diets in severe pancreatic insufficiency. Scand J Gastroenterol 28:749–752
Abrams CK, Hamosh M, Dutta SK, Hubbard VS, Hamosh P (1987) Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. Gastroenterology 92:125–129
Graham DJ (1972) Enzyme replacement therapy of exocrine pancreatic insufficiency. N Engl J Med 296:1314–1317
Mariani A, Bocchia P, Basilico M, Malesci A (1992) Efficacy of a new pancreatic extract in the treatment of steatorrhea due to chronic pancreatitis. Ital J Gastroenterol 24:164
Dobrilla G (1989) Management of chronic pancreatitis. Focus on enzyme replacement therapy. Int J Pancreatol 5:17– 29
Marotta F, O’Keefe SJ, Marks IN, Girdwood A, Young G (1989) Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2 antagonists and enteric-coating. Dig Dis Sci 3:456 – 461
Linehan JP, Lambert MA, Brown DC, Kurtz AB, Cotton PB, Russell RCG (1988) Total pan-createctomy for chronic pancreatitis. Gut 29:358 –365
Vantini I, Lucchin L, Piubello W, Brocco G, Marchiaro G, Benini L, Cavallini G, Scuro LA (1981) In vitro comparison of enzymatic activities in 19 enzyme-containing commercial preparations marketed in Italy. Ital J Gastroenterol 13:190–192
Otte M, Gutowski HD, Mackenroth T (1991) In vitro testing of pancreatic enzyme preparations. In: Lankisch PG (ed) Pancreatic enzyme in health and disease. Springer, Berlin Heidelberg New York, pp 65 – 70
Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568
Ruyssen R, Lauwers A (1978) Pharmaceutical enzymes. Story Scientia, Gent, pp 57–84
Reynolds JEF (1989) Martindale. The extra pharmacopoeia, 29th edn. Pharmaceutical Press, London
Thiruvengadam R, Di Magno EP (1988) Inactivation of human lipase by proteases. Am J Physiol 255 : G476 – G481
Pap A, Varro V (1986) Replacement therapy in pancreatic insufficiency with a new pan-creatin preparation as the cause of the excellent results of replacement therapy. Dig Dis Sci 31:519
Pap A, Varro V (1988) Replacement therapy in pancreatic insufficiency with a new pan-creatin preparation respecting the physiological ratio of lipase/trypsin activity. Hepato-gastroenterology 35:83 – 86
Slaff J, Jacobs D, Tillman CR, Currington C, Toskes P (1984) Protease specific suppression of pancreatic exocrine secretion. Gastroenterology 87:44–52
Lankisch PG (1991) Differential treatment of exocrine pancreatic insufficiency in chronic pancreatitis. In: Lankisch PG (ed) Pancreatic enzymes in health and disease. Springer, Berlin Heidelberg New York, pp 191–208
Halgreen H, Thorsgaard Pedersen N, Worning H (1986) Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 21:104 –108
Isaksson G, Ishe I (1983) Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 28:97 –102
Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P (1984) Protease specific suppression of pancreatic secretion. Gastroenterology 87:44 –52
Malesci A, Gaia E, Vantini I, Bocchia P, Fioretta A, Ciravegna CP (1990) Effect of pancreatic extract therapy on abdominal pain in chronic pancreatitis: a 4 months double blind crossover study. Gastroenterology 5 : A 228
Mössner J, Secknus R, Meyer J, Niederau C, Adler G (1991) Treatment of pain with pancreatic extracts in chronic pancreatitis. Gastroenterology 100 : A290
Di Magno EP, Go VLW, Summerskill WHJ (1973) Relation between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815
Lankisch PG, Lembke B, Wemken G, Creutzfeldt W (1986) Functional reserve capacity of the exocrine pancreas. Digestion 35:175 –181
Gaskin KJ, Durie PR, Lee L, Durie PR (1984) Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Gastroenterology 86:1–7
Zerega J, Lerner S, Meyer H (1988) Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency. Dig Dis Sci 33:1245–1249
Kelly DG, Sandberg RJ, Bentley KJ, Zinsmeister AR, Di Magno EP (1988) Protection of lipolytic activity by nutrients in simulated pancreatic insufficiency. Pancreas 3:601
Dekehart MR, Dutta SK, Vaeth J (1989) Dietary fiber supplementation: effect on exocrine pancreatic secretion in man. Am J Clin Nutr 50:1023 –1028
Dutta SK, Hlasko J, (1985) Dietary fiber in pancreatic disease: effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr 41:517–525
Gullo L, Pezzilli R, Cassano A, Ligabue A, Ventrucci M, Barbara L (1988) Clinical effectiveness of a new enteric-coated pancreatic enzyme extract in the treatment of the pancreatic steatorrhea. Curr Ther Res 44:105 –109
Fioretta A, Bonfante F, Caliari S, Brentegani MT, Scattolini C, Benini L, Vantini I (1992) Effect of a new pancreatic supplement (enteric-coated microtablets) with a very high lipase content on faecal fat excretion in patients with exocrine pancreatic insufficiency. Ital J Gastroenterol 24:160
Elashoff J, Porter-Fink V, Dressman J, Amidon G (1987) What should be the size of pancreatin microspheres? Gastroenterology 92:1533
Vantini I, Fioretta A, Brocco G, Benini L, Sembenini C, Scuro LA (1987) Attività nel lume duodenale di un nuovo preparato contenente enzimi pancreatici. Ter Mod 4:145–150
Dutta SK, Rubin J, Jeffrey H (1983) Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 84:476–482
Regan PT, Malagelada JR, Di Magno EP, Go VLW (1979) Postprandial gastric function in pancreatic insufficiency. Gut 20:249 – 254
Cortot A, Jobin G, Ruskone A, Bernier JJ (1981) Rapid gastric emptying of lipids in pancreatic insufficiency in man. Gastroenterology 80:1129
Long WB, Weiss JB (1974) Rapid gastric emptying of fatty meals in pancreatic insufficiency. Gastroenterology 67:920 – 925
Meyer JH (1991) Delivery of pancreatin in microsphere preparations: transit, timing, physiological needs. In: Lankisch PG (ed) Pancreatic enzymes in health and disease. Springer, Berlin Heidelberg New York, pp 71 – 88
Sirois PJ, Amidon GL, Meyer JH, Doty JE, Dressman JB (1990) Size and density discrimination of nondigestible solids during gastric emptying in dogs: a hydrodynamic correlation. Am J Physiol 258 : G65 – G72
Heizer WD, Cleaveland CR, Iver FL (1965) Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270
Di Magno EP (1982) Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 27:4811–484
Piubello W, Vantini I, Novelli P, Scuro LA, Benini L, Brocco G, Cavallini G (1982) Gastric secretion, gastroduodenal histological changes and serum gastrin in chronic alcoholic pancreatitis. Am J Gastroenterol 77:105–110
Saunders JHB, Cargill JM, Worsmley KG (1978) Gastric secretion of acid in patients with pancreatic disease. Digestion 17:365–369
Ovensen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ (1986) Intraluminal pH in the stomach, duodenum and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90:958–962
Dutta SK, Russell RM, Iber FI (1979) Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529–534
Dutta SK, Russell RM, Iber FI (1979) Impaired acid neutralization in the duodenum in pancreatic insufficiency. Dig Dis Sci 44:775–780
Zentler-Munro PL, Fine DR, Batten JC, Northfield TC (1985) Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilization in pancreatic steatorrhea due to cystic fibrosis. Gut 26:892–901
Younberger CA, Berardi RR, Howatt WF, Hyneck ML, Amidon GL, Meyer JH, Dressman JB (1987) Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 32:472–480
Regan PT, Malagelada JR, Go VLW (1976) Use of cimetidine with oral pancreatic replacement in cystic fibrosis. Clin Res 24:567
Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1977) Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858
Regan PT, Malagelada JR, Di Magno EP, Go VLW (1978) Rationale for use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 53:79–83
Gow R, Bradbear R, Francis P, Shepherd R (1981) Comparative study of varying regimens to improve steatorrhoea and creatorrhoea un cystic fibrosis: effectiveness of an enteric-coated preparation with and without antacid and cimetidine. Lancet 2:1071–1074
Lankisch PG, Lembcke B, Goke B, Creutzfeldt W (1983) Therapy of pancreatogenic steatorrhea: does acid protection of pancreatogenic enzymes offer any advantages? Digestion 28:43
Boyle BJ, Long WB, Balistrieri WF, Widzer SJ, Huang N (1980) Effect of cimetidine and pancreatic enzymes on serum and faecal bile acids and fat absorption in cystic fibrosis. Gastroenterology 78:950 – 953
Gullo L, Corinaldesi R, Casadio R (1983) Gastric acid secretion in chronic pancreatitis. Hepatogastroenterology 30:60 – 62
Bianchi Porro G, Dolcini R, Grossi E, Petrillo M, Prada A (1977) Cimetidine in treatment of pancreatic insufficiency. Lancet 2:878 – 879
Lamers CBHW (1986) Omeprazole as adjunct to enzyme replacement treatment in severe pancreatic insufficiency. Br Med J 239:994
Dutta SK, Hubbard VS, Appier M (1988) Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in the treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. Dig Dis Sci 33:1237–1244
Guarner L, Rodriguez R, Malagelada JR (1989) Ileal vs. duodenal enzyme activities in treated and untreated pancreatic steatorrhea. Gastroenterology 96: A187
Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W (1985) Pancreatic enzyme replacement therapy: comparative effects of conventional enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis. Hepatogastroenterology 32:97–102
Vantini I, Fioretta A, Caliari S, Benini L, Brentegani MT, Castellani G, Bonfante F (1990) Effects of two pancreatic enzyme-containing enteric-coated microsphere preparations on steatorrhea in chronic alcoholic pancreatitis. Curr Ther Res 48:1 – 7
Mitchell EA, Quested C, Marks ER (1987) Comparative trial of Viokase, pancreatin and Pancrease pancrealipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis. Aust Pediatr J 42:114–117
Stead RJ, Skypala I, Hodson ME, Batten JC (1987) Enteric-coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric-coated preparation. Thorax 42:533–537
Braggion C, Borgo G, Faggionato P, Mastella G (1987) Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 62:349–356
Chazalette JP, Dain MP, Castaigne JP (1988) Efficacy of Pancrease. Crossover comparative study versus Eurobiol in cystic fibrosis. J Pediatr Gastroenterol Nutr 7:46–48
Bouquet J, Sinaasappel M, Neijens HJ (1988) Malabsorption in cystic fibrosis: mechanism and treatment. J Pediatr Gastroenterol Nutr 7:30–35
Ansaldi-Balocco N, Santini B, Sarchi C (1988) Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study of the same patients at two different ages. J Pediatr Gastroenterol Nutr 7:40 –45
Littlewood JM, Kelleher J, Walters MP, Johnson AW (1988) In vivo and in vitro studies of microsphere pancreatic supplements. J Pediatr Gastroenterol Nutr 7:22–29
Carroccio A, Pardo F, Montalto G et al. (1988) Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long term comparative study. Digestion 41:201–206
Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568
Dobrilla G, Bonoldi MC, Chilovi F (1980) Effect of cimetidine on pancreatic function and disease. In: Torsoli A, Lucchelli PE, Brimblecombe RW (eds) Further experience with H2-receptor antagonists in peptic ulcer disease and progess in histamine research. Ex-cerpta Medica, Amsterdam, pp 148–161
Staub JL, Sarles H, Soule JC, Galmiche JP, Caprow JP (1981) No effect of cimetidine on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 304:1364–1365
Graham DY (1982) Pancreatic enzyme replacement: effect of antacids or cimetidine. Dig Dis Sci 27:485–490
Scuro LA, Vantini I (1987) Nutritional problems and support in chronic pancreatitis. In: Barbara L (ed) Nutrition and gastrointestinal disease. Raven, New York, pp 273–283
Carroccio A, Pardo F, Montalto G, Iapichino L, Soresi M, Averna MR, Iacono G, Notarbar-tolo A (1992) Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis. Dig Dis Sci 37:1441–1446
Worning H (1980) The effect of enzyme substitution in patients with pancreatic insufficiency. Scand J Gastroenterol 15:529–533
Braga M, Cristallo M, De Franchis R, Mangiagalli A, Agape D, Primignani M, Di Carlo V (1988) Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function. Surg Gynecol Obstet 167:485–492
Braga M, Cristallo M, De Franchis R, Mangiagalli A, Zerbi A, Agape D, Primignani M, Di Carlo V (1989) Pancreatic enzyme replacement therapy in postpancreatectomy patients. Int J Pancreatol 5:37–44
Domschke S (1991) Trattamento della steatorrea pancreatica, resistente alia terapia enzimatica sostitutiva convenzionale. In: Dobrilla G, De Pretis G, Piazzi L (eds) Non-responders in gastroenterologia: cause e trattamento. Cortina, Verona, pp 235 – 244
Armbrecht U, Lundell L, Lindstedt G, Stockbrugger RW (1988) The causes of nutrient malassimilation after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 154:37–41
D’Orazio C, Pederzini F, Fratton M, Crema C, Perobelli S, Mastella G (1992) Fattibilità della supplementazione nutrizionale con gastrostomia in fibrosi cistica. In: Bosco A (ed) Atti, P93
Silk DBA (1986) Diet formulation and choice of enterai diet. Gut 27:40– 46
Cristallo M (1986) L’ alimentazione enterale spéciale nelle pancreatiti croniche. Schede Inform 2 :119-122
Dutta SK, Narang A, Nasrallah SM, Iber FL (1981) Evaluation of the efficacy of elemental diet therapy in patients with chronic alcoholic pancreatitis. Gastroenterology 84:1130
Kornowski A, Cosnes J, Gendre JP, Quintrec Y (1992) Enterai nutrition in malnutrition following gastric resection and cephalic pancreaticoduodenectomy. Hepatogastroenterol 39:9–13
Durie PR, Newth CJ, Forstner GG, Gall DG (1980) Malabsorption of medium-chian triglycérides in infants with cystic fibrosis: correction with pancreatic enzyme supplements. JPediatr 96:862–864
Di Carlo V, Chiesa R (1984) Intraductal injection of neoprene to suppress pancreatic exocrine secretion in humans. Clinical and metabolic evaluation. Transplant Proc 16: 736–738
Jeejeebhoy KN, Ahmad A, Kozak G (1970) Determination of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 3:157–163
Caliari S, Benini L, Brentegani MT, Bonfante F, Castellani G, Fioretta A, Bardelli E, Vantini I (1992) Medium chain triglycerides in exocrine pancreatic insufficiency: evaluation of absorption by chemical methods. Gut 33:22
Griffin SM, Alderson D, Farndon JR (1989) Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs. Gut 30:1012–1015
Zentler-Munro PL, Assoufi BA, Balasubramanjan K, Cornell S, Benoliel D, Northfield TC, Hodson ME (1992) Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhea due to cystic fibrosis. Pancreas 7:311–319 (1992)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Vantini, I., Benini, L., Caliari, S., Fioretta, A. (1994). What Kind of Pancreatic Extracts To Use?. In: Pederzoli, P., Cavallini, G., Bassi, C., Falconi, M. (eds) Facing the Pancreatic Dilemma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79167-3_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-79167-3_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58284-7
Online ISBN: 978-3-642-79167-3
eBook Packages: Springer Book Archive